FYN and synovial sarcoma: Collectively, these observations reinforce the involvement of FYN in synovial sarcoma cell response to HDACi treatment, and suggest that inhibition of FYN activity may be a therapeutic strategy to enhance the effectiveness of HDACi treatment for synovial sarcoma.